Compare WST & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | LI |
|---|---|---|
| Founded | 1923 | 2015 |
| Country | United States | China |
| Employees | N/A | 30728 |
| Industry | Medical/Dental Instruments | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5B | 18.0B |
| IPO Year | 2004 | N/A |
| Metric | WST | LI |
|---|---|---|
| Price | $322.77 | $18.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 10 |
| Target Price | ★ $325.86 | $19.66 |
| AVG Volume (30 Days) | 919.8K | ★ 2.3M |
| Earning Date | 04-23-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.30% | N/A |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $2,886,900,000.00 | N/A |
| Revenue This Year | $6.76 | $18.98 |
| Revenue Next Year | $6.22 | $22.72 |
| P/E Ratio | $170.25 | ★ $29.50 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $203.74 | $15.71 |
| 52 Week High | $328.44 | $32.03 |
| Indicator | WST | LI |
|---|---|---|
| Relative Strength Index (RSI) | 73.90 | 60.49 |
| Support Level | $234.43 | $16.30 |
| Resistance Level | N/A | $18.94 |
| Average True Range (ATR) | 9.38 | 0.37 |
| MACD | 2.16 | 0.02 |
| Stochastic Oscillator | 86.19 | 83.85 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.